Risk factor
Meaningful price volatility
Profitability factor
Greatly overvalued vs peers
About
Shanghai General Healthy Information and Technology Co., Ltd. (SGHIT) delivers a range of advanced solutions to the healthcare sector in China. These encompass automated pharmaceutical logistics, cutting-edge information technology, and intelligent, mobile medical applications. Its core product portfolio features the "Smart Pharmacy Project," an integrated hardware and software system designed for intelligent medication management. Another key offering is the "Intelligent Static Distribution Center Project," a sophisticated system for the configuration and oversight of intravenous medications. Additionally, the "Intelligent Drug Consumables Management Project" provides specialized oversight for various pharmaceutical supplies, including controlled substances and high-value medical items. Established in 2014, SGHIT operates from its headquarters in Shanghai, China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of 605186.SS is 23.9 and suggests 3.67% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation